Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
The FDA rules released Wednesday also call for voluntary extra nutrition labels that note when the drinks have lower levels of nutrients than dairy milk. → Read More
The first limits on added sugars would take effect in the 2025-2026 school year, targeting high-sugar foods such as sweetened cereals, yogurts and flavored milk. → Read More
The move comes after repeated calls from lawmakers, advocates and consumer groups for CBD to be allowed in foods and supplements. → Read More
The official specifically referenced the baby formula shortage that struck the U.S. last year as an example of what happens when the FDA can't function effectively. → Read More
It’s the first drug of its type approved for animals; similar drugs have been approved for people for about a decade. → Read More
New guidance recommends doctors offer obesity drugs to kids as young as 12, and referrals for weight-loss surgery to kids as young as 13. → Read More
The longstanding practice of “watchful waiting," or delaying treatment to see whether children outgrow or overcome obesity on their own only worsens the problem. → Read More
U.S. health officials have revised a tool to track the rising cases of severe obesity among children who were previously off the charts. Updated growth → Read More
The old scale, which went up to 37, has been in use for more than two decades, even as the rate of childhood obesity in the U.S. has nearly quadrupled. → Read More
The top 12 states using antibody therapies produced by Regeneron and Lilly — which research shows don’t work against the omicron variant — include several Southern states with some of the nation’s … → Read More
The promising antiviral drugs to treat covid can halt hospitalizations and deaths, but only if they’re given to patients within three to five days of their first symptoms, a narrow window many peop… → Read More
A federal allocation plan meant to ensure equitable distribution of powerful monoclonal antibody treatments for high-risk patients fails to prioritize nursing home residents, a population that rema… → Read More
At issue is whether transplant patients who refuse the shots are not only putting themselves at greater risk for serious illness and death from covid-19, but also squandering scarce organs that cou… → Read More
At least three promising antivirals for COVID-19 are in clinical trials. Antivirals already treat other infections, including hepatitis C and HIV. → Read More
At least three promising antiviral treatments for covid-19 are being tested in clinical trials, with results expected as soon as late fall or winter. → Read More
At least three promising antiviral treatments for covid-19 are being tested in clinical trials, with results expected as soon as late fall or winter. → Read More
The House oversight committee is requesting conflict-of-interest disclosure forms from a National Academies committee studying organ transplants. KHN previously reported on apparent conflicts among… → Read More
Seattle’s Northwest Kidney Centers, which pioneered kidney failure treatment 50 years ago, now pairs dying patients with hospice services, without forcing them to forgo the comfort dialysis can pro… → Read More
Governors in Southern states, amid a surge of delta-variant infections, are rushing to provide an experimental antibody cocktail therapy, even as they oppose measures like mask mandates and vaccine… → Read More
In another twist on covid vaccine hesitancy, blood centers say they are starting to hear from transfusion patients demanding blood from unvaccinated donors. Experts say the option is neither practi… → Read More